Important investor alert: khang & khang llp announces securities class action lawsuit against davita inc. and encourages investors with losses to contact the firm

Irvine, calif.--(business wire)--khang & khang llp (the “firm”) announces the filing of a class action lawsuit against davita inc. (“davita” or the “company”) (nasdaq: dva). investors who purchased or otherwise acquired shares between august 5, 2015 and october 21, 2016 inclusive (the “class period”), are encouraged to contact the firm in advance of the april 3, 2017 lead plaintiff motion deadline. if you purchased shares of davita during the class period, please contact joon m. khang, esquire, of khang & khang, 18101 von karman avenue, 3rd floor, irvine, ca 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com. there has been no class certification in this case. until certification occurs, you are not represented by an attorney. you may choose to take no action and remain a passive class member. on january 6, 2017, the wall street journal announced davita had received subpoenas from federal prosecutors for "the production of information related to charitable premium assistance" concerning the company’s relationship with the american kidney fund, a charity that offers financial help for patients undergoing kidney dialysis. when this information was released to the public, the value of davita stock fell, causing investors severe harm. if you have any questions concerning this notice or your rights, please contact joon m. khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com. this press release may constitute attorney advertising in some jurisdictions.
DVA Ratings Summary
DVA Quant Ranking